3 February 2016
EMEA/29277/2003 v.4
Human Medicines Evaluation Division
Appendix III to the QRD templates for human medicinal products
This appendix should be read together with the Note for Guidance on the Declaration of Storage Conditions A) in the product information of medicinal products, and B) for active substances (EMEA/CPMP/QWP/609/96/Rev 2).
The purpose of the Note for Guidance is to set out uniform statements on storage conditions for inclusion in the product information of medicinal products and labelling of active substances and to define when they apply. The CHMP adopted a revision of this document in November 2007, which resulted in amendments of/or additions to the required storage statements.
Storage Conditions
|
BG Bulgaria
|
IT Italian
|
CS Czech
|
LT Lithuanian
|
DA Danish
|
LV Latvian
|
DE German
|
MT Maltese
|
EL Greek
|
NL Dutch
|
EN English
|
NO Norwegian
|
ES Spanish
|
PL Polish
|
ET Estonian
|
PT Portuguese
|
FI Finnish
|
RO Romania
|
FR French
|
SK Slovak
|
HR Croatian
|
SL Slovenian
|
HU Hungarian
|
SV Swedish
|
IS Icelandic
|
|
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
An agency of the European Union
Telephone
+44 (0)20 3660 6000
Facsimile
+44 (0)20 3660 5515
Send a question via our website www.ema.europa.eu/contact
© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.
Dostları ilə paylaş: |